Procedure |
Prothrombin Time on the Coaguchek Analyzer |
Prepared by |
Date Adopted |
Supersedes Procedure |
|
|
New
Procedure |
Review Date |
Revision Date |
Signature |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributed to |
No.
of Copies |
Distributed to |
No.
of Copies |
Hematology
Department |
1 |
|
|
Pathology
Department |
1 |
|
|
|
|
|
|
|
|
|
|
PRECAUTION:
WHILE PERFORMING THIS PROCEDURE, THE FOLLOWING SAFETY
MEASURES MUST BE TAKEN: GLOVES MUST BE WORN; SMOKING, EATING, DRINKING,
APPLICATION OF COSMETICS, AND MANIPULATION OF CONTACT LENSES ARE PROHIBITED
IN ALL TECHNICAL WORK AREAS. REFER TO
THE UNIVERSAL PRECAUTIONS POLICIES. |
CLIA
Complexity: Moderate
I. Method:
The
Prothrombin Time (PT) is measured using the CoaguChek System. When used correctly, this system may be used
to monitor the oral anticoagulant (warfarin) level of patients to ensure its
level is maintained in the therapeutic range.
II. Principle:
When
a drop of fresh blood is placed on the test strip, the blood is drawn into a
reaction chamber and mixed with reagents that start the coagulation
process. Tiny iron particles are also
mixed with the test strip sample, and alternating magnetic fields cause the
iron particles to move. The endpoint of
the test is reached when the blood clot stops the iron particles from
moving. The monitor then displays the
PT result.
III. Materials
C
The CoaguChek Monitor with the proper Code Chip
installed. Each Code Chip is specific
to a particular lot of test strips. A
Code Chip is inserted into the CoaguChek monitor each time a new box of test
strips is opened. The Code Chip
contains programming information about the test type, lot number, expiration
date, and function curve.
Storage of Code Chip: The Code Chip
must not be exposed to moisture or devices that produce magnetic fields.
C
The CoaguChek Test Strips which contains non-human
thromboplastin, stabilizers, and preservatives.
Storage of strips: Strips are stored in
the refrigerator (2° to 8°C) until
ready for use. Do not freeze! When stored at room temperature, test strips
are stable for 60 days or until the expiration date, whichever comes
first. Only the number of foil pouches
necessary for testing should be removed from the refrigerator. Allow the sealed pouches to sit at room temperature
for at least five minutes before opening for the testing procedure. The test strip must be used within four
minutes after opening the sealed pouch.
C
Lancets (For capillary sample collection)
C
Plastic syringes free of anticoagulant (For venous sample
collection)
C
Alcohol wipes
C
Cotton balls or gauze
C
Disposable gloves
IV. Specimen Collection and Handling:
No
special patient preparation is necessary.
The patient’s identity must be verified prior to drawing the blood
specimen. This can be done by examining
the inpatient’s arm band or the by verbally verifying the patient’s name and
date of birth with the patient or parent/guardian.
Sample
size: Minimum of 25ul of blood.
CoaguChek
PT tests may be performed with fresh capillary whole blood from a fingerstick
or fresh venous whole blood drawn in an anticoagulant-free plastic
syringe.
Criteria
for rejecting specimens:
C
Plasma or serum cannot be used as a testing sample.
C
Patient cannot be on heparin therapy. Heparin interferes with the CoaguChek test.
C
Sample size cannot be less that 25ul.
C
Venous sample cannot be collected in a syringe containing
anticoagulant.
C
Sample must be used immediately after collection.
C
Glass tubes or glass syringes may not be used (plastic is
acceptable).
C
Additional blood sample should not be added to the test
strip once testing has begun.
V. Calibration
The
Code Chip supplied with each box of test strips automatically calibrates the
monitor for that particular lot of strips.
In addition, every time the monitor is turned on, it goes through an
automatic diagnostic check. The user
does not need to do additional calibration testing.
VI. Quality Control
The
quality control products are intended to verify proper instrument and test
performance, as well as operator technique.
Materials
Needed:
C
The CoaguChek Monitor with the proper Code Chip installed
C
The CoaguChek Test Strips which contains non-human
thromboplastin, stabilizers, and preservatives.
C
CoaguChek Liquid Controls
Storage: CoaguChek Liquid Controls are
to be stored in the refrigerator (2° to 8°C). Do not freeze! If stored in the refrigerator, controls are stable until the
manufacturer’s expiration date. When
stored at room temperature, controls are stable for 30 days or the expiration
date, whichever comes first.
Frequency:
Two
levels of quality control (normal and abnormal) must be performed every 8 hours
on days that patient testing occurs.
Controls should also be run after any maintenance procedures and
whenever the patient values do not match the expected results. It is the responsibility of the personnel
performing the patient testing to perform quality control.
CoaguChek
Liquid Quality Control Test Procedure:
NOTE:
Only the number of controls necessary to perform the test(s) should be removed
from the refrigerator. The controls and
test strips need to be brought to room temperature 5 minutes before testing.
1. Preparation of control solution:
a.
Pull the tab on the control vial to remove perforated seal.
b.
Holding vial upright, tap vial on the tabletop to settle the glass
capsule to the bottom of the vial.
c.
Squeeze the lower half of the control vial to break the glass
capsule. Use both hands if necessary. The capsule must break.
Do not bend the vial. Bending
may cause the glass to cut through the exterior wall of
the plastic vial. Do not mix contents
by rolling between thumb and forefinger.
d.
Set a timer for 2 minutes.
Holding the vial upright, immediately tap the vial hard on the tabletop 10 times to mix reagents.
e.
Set the control aside and do not disturb the vial for the remainder of
the 2 minutes.
f.
After the 2 minutes have passed, open the foil pouch and remove the test
strip to begin testing.
2. Turn the monitor on and ensure proper
time, date and operating conditions.
PERFORM TEST? Should appear on the display.
3. Press YES button on monitor. INSERT STRIP appears on the display.
4. Insert strip into monitor, printed side
up, until the monitor displays IS THIS A CONTROL?
5. Press YES on monitor. The monitor displays PLEASE WAIT.
6. After 45 seconds, the monitor will
display APPLY SAMPLE. When monitor
displays APPLY SAMPLE, shake
down the contents of the vial toward the dropper end. Shake down hard.
7. Hold the vial dropper-end down and remove
the cap. Save the cap.
8. Discard the first drop of control
solution into the cap. Discard the cap.
9. Allow a large, hanging drop of control
solution to form from the dropper.
Gently touch drop to the center of the test strip’s yellow sample target
area. The drop must contact the
half-moon shaped channel at the top of the target area. The sample must completely cover the target
area.
10. The monitor displays TESTING along with a
progress bar. During this time, do not disturb the strip or add more control
solution to the strip.
11. The PT control value is displayed followed
by a “C”. Compare the control value to
the CoaguChek Control Results
Sheet.
12. Record the control value on a quality
control log.
13. Properly discard the used test strip
and the control vial.
Acceptable
Quality Control Ranges:
Acceptable
CoaguChek Liquid Control ranges are found on the CoaguChek Control Result
Sheet.
If
the quality control test results are outside the acceptable control range,
patient testing can not occur until corrected.
All results out of range are to be repeated. All corrective actions are to be documented on the testing log. If repeating the control still yields an out
of range result, the following corrective action is recommended:
Step |
Action |
1 |
Make sure strips and controls were
stored correctly and have not expired. |
2 |
Make sure the foil pouch was not
opened longer that 4 minutes. |
3 |
Make sure the control was mixed
thoroughly after breaking the glass capsule. |
4 |
Make sure the control was used within
two to four minutes of breaking the capsule in the vial. |
5 |
Clean the monitor as recommended in
the CoaguChek User=s Manual, and repeat the test. |
6 |
If results are still unacceptable,
call Roche-Boehringer Mannheim Technical Service at 1-800-428-4674, 24 hours
a day, 365 days a year. |
VII. Maintenance
The
interior and exterior parts of the CoaguChek Monitor should be cleaned each
time a new Test Kit is opened. If the
monitor becomes contaminated with blood, it should be disinfected with a 10%
bleach solution.
Cleaning
the interior:
1. Press the door release and lift the door
to the fully opened position.
2. Clean the test strip guide with a
cotton-tipped swab dampened with a 10% bleach solution.
3. Clean the underside of the door with a
lint-free wipe.
4. Dry the test strip guide and underside of
door with a lint-free wipe. Allow it to
air dry for 10 minutes.
Cleaning
the exterior:
1. Wipe the outside of the monitor with a
clean cloth slightly dampened with a solution of 1 part bleach and 9 parts water. Do not flood the monitor.
VIII. Quality Assurance:
Quality
control results and maintenance is reviewed monthly by the Point-of-Care
Testing Medical Technologist (or designee).
Quality Assurance reports are completed and distributed monthly to each
testing area for review.
IX. Patient Testing Procedure:
1. Place the monitor on a flat surface free
of vibrations and turn it on.
2. When PERFORM TEST? appears on the
display, press YES.
3. INSERT STRIP appears on the
display. Open the foil pouch at the
tear mark and remove the test
strip. NOTE: You must use the strip
within 4 minutes of opening the foil pouch.
4. Insert the test strip into the monitor in
the direction of the printed arrows, printed side up. The monitor displays IS THIS A CONTROL?
5. Press NO.
6. When APPLY SAMPLE appears on the display,
obtain the venous or capillary blood sample. (See Specimen Collection and Handling
section)
a) Direct capillary application-
Apply blood directly from the finger to the test strip.
NOTE: The first drop of blood should be used.
b) Using a capillary tube- Touch
the capillary tube to the drop of blood.
Keep the tube level and allow it to fill by capillary
action. Put the finger over the hole in
the end of the capillary tube. Hold the capillary tube directly over the
sample target and expel sample.
NOTE: Avoid getting air bubbles into the sample.
c) Using a Venous Sample- Expel
one to two drops of blood from the syringe needle. Then place one drop of blood from the
syringe needle directly onto the sample target area of the test strip.
7. Completely cover the yellow sample
target area. The sample must contact
the upper part of the target area.
8. A progress bar is displayed to show how
much time is left before the test is complete.
All 16 boxes will be filled in
when the test is complete.
9. The result will appear in about 2
minutes. Document the result in the
patient chart.
X. Patient Results
All
results are recorded in the patient’s chart.
The
normal range for prothrombin time established here at XXXXXl Hospital is
11.9
to 14.5 seconds.
The
physician should determine the best PT level for the patient depending on the
reason for anticoagulant treatment and how each individual responds to
treatment. Each physician should
establish expected values for his or her patient population or individual
patients.
Any
unexpected result should be followed up with appropriate coagulation studies
and inquiries to define the cause of the unusual result.
XI. Limitations of Procedure
C
Fresh capillary or venous whole blood should be used on the
CoaguChek Monitor. For capillary
samples, the first drop of blood should be used. Plasma and serum are not acceptable.
C
Samples are collected using plastic syringes without
anticoagulants or additives. Glass
tubes or syringes are not to be used.
C
The volume of the blood drop must be a minimum of 25ul. Low sample volume will cause a SAMPLE
ERROR-REMOVE STRIP warning.
C
In rare cases, patients with long clotting times (>9 INR,
>36 sec.) may observe test errors.
If test errors persist, results must be confirmed with an alternative
test method.
C
The CoaguChek test measures PT results in persons on
warfarin-type (Coumadin) therapy. This
test is not used to monitor persons on heparin therapy. In vitro studies have shown that the
CoaguChek System is sensitive to levels of heparin over 0.15U/mL.
C
If a patient is on intravenous infusion therapy, the sample
should not be collected from the same arm.
C
Hematocrit ranges from 32% to 52% do not significantly
affect test results.
C
No interference has been found in lipemic samples containing
up to 500 mg/dl of triglycerides. In
tests performed with in vitro-spiked samples, bilirubin up to 20mg/dl and
hemolysis up to 500 mg/dl did not significantly affect test results.
XII. References
CoaguChek
System Policies and Procedure. 81997
Boehringer Mannheim Corporation.